Skip to content

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

Sister Survivor: Improving the Survivorship Care of African-American Women With Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01450020
Enrollment
145
Registered
2011-10-12
Start date
2012-06-01
Completion date
2026-10-01
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

cancer survivor

Brief summary

This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the ability of peer navigation (PN) to improve understanding of survivorship care planning (SCP) at 6 months. II. To promote adherence to the SCP schedule of follow-up examinations at 12 months. SECONDARY OBJECTIVES: I. To evaluate the effect of PN on change from baseline in medical efficacy, preparedness for life as new survivor, and physical and health related QOL at 6 months. OUTLINE: PNs are trained on medical issues and resources, and SCP. Participants are then randomized to 1 of 2 treatment arms. ARM I: Participants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and American Cancer Society (ACS) materials. ARM II: Participants receive ACS materials. After completion of study treatment, patients are followed up at 6 and 12 months.

Interventions

OTHEReducational intervention

Receive ACS material

OTHERquestionnaire administration

Ancillary studies

OTHERcounseling intervention

Undergo PN session

OTHERsurvey administration

Ancillary studies

PROCEDUREquality-of-life assessment

Ancillary studies

Sponsors

City of Hope Medical Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* TRIAL SUBJECTS: * Patient age 18 years or older who self-identifies as African-American * In early survivorship phase, defined as being 1-12 months post completion of treatment for stage 0-3 breast cancer * Receiving health care primarily through an health maintenance organization (HMO) * Patients with metastatic cancer or a second primary cancer, because their medical characteristics (e.g. disease progression) are significantly different * Breast cancer survivors (BCS) with other major disabling medical, psychiatric, or substance abuse conditions (e.g., anxiety, depression, alcohol/tobacco problems) will be excluded * PEER NAVIGATORS: * At least 25 years of age who self-identifies as African-American * Previously participated in any type of research study * Has at least high school education * Has been diagnosed with breast cancer, currently in remission or eradicated * Belongs to a breast cancer support group * Has a valid driver's license * Owns an operational vehicle * Has access to a personal computer with internet access

Design outcomes

Primary

MeasureTime frameDescription
Ability of peer navigation to improve understanding of SCPAt 6 monthsChi-square and t-tests will be used to compare the baseline characteristics of subjects randomized to PN intervention vs control. For subjects in the intervention arm, the number of navigation sessions received will be reported, and correlated factors will be explored. The number of subjects navigated per PN will also be reported. Nonevaluable and evaluable subjects (defined at 6 and 12 months) will be compared. Site of care will be handled as a cluster level variable in generalized linear mixed (GLM) regression models.
Adherence to the SCP schedule of follow-up examinationsAt 12 monthsMeasured using a newly created, 50-point scale that gives equal weight to completion of the recommended: physical exams, imaging, pelvic exam, annual oncology visit, and breast self-exams.

Secondary

MeasureTime frameDescription
Effect of PN on change in medical efficacyBaseline to 6 monthsExploratory analyses will analyze the effect of PN intervention actually received, using the number of PN sessions completed and the quality of the subject's PN as measured by PN's post-training level of acuity and utility.
Preparedness for life as new survivor (PLANS)At 6 monthsPLANS consists of two subscales that measure patients' knowledge and self efficacy with regards to their Access and Quality of Survivorship Care Plan (SCP) and adherence with regard to following these tasks. The knowledge subscale (Cronbach's alpha 0.90) and adherence subscale (Cronbach's alpha 0.70) have good reliability.
Physical and health related QOLAt 6 months

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKimlin Ashing-Giwa

City of Hope Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026